Nurix Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.5M | 68k | 22.47 |
| 2024-06-30 | $768k | 37k | 20.87 |
| 2024-03-31 | $515k | 34k | 15.00 |
| 2023-12-31 | $495k | 48k | 10.32 |
| 2023-09-30 | $416k | 53k | 7.86 |
| 2023-06-30 | $528k | 53k | 9.99 |
| 2023-03-31 | $2.0k | 190 | 10.53 |
| 2022-12-31 | $979k | 89k | 10.99 |
| 2022-06-30 | $1.6M | 130k | 12.68 |
| 2022-03-31 | $1.7M | 121k | 13.98 |
| 2021-12-31 | $2.6M | 90k | 28.94 |
| 2021-03-31 | $370k | 12k | 31.08 |
| 2020-12-31 | $172k | 5.2k | 32.96 |
| 2020-09-30 | $138k | 4.1k | 33.33 |